Sugiyama Y, Fujita T, Matsumoto M, Okamoto K, Imada I
J Pharmacobiodyn. 1985 Dec;8(12):1006-17. doi: 10.1248/bpb1978.8.1006.
The effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in isolated brain mitochondria from rats and dogs were studied. CV-2619 was easily reduced by canine brain mitochondria in the presence of respiratory substrates. Reduced CV-2619 (2H-CV-2619) was rapidly oxidized through the cytochrome b chain, indicating that the compound functioned simply as an electron carrier of mitochondrial respiratory system. Both nicotinamide adenine dinucleotide (NADH)- and nicotinamide adenine dinucleotide phosphate (NADPH)-dependent lipid peroxidations were examined in canine brain mitochondria in the presence of adenosine diphosphate (ADP) and Fe3+. NADH-cytochrome c reductase activity was sensitive to NADPH-dependent lipid peroxidation. CV-2619 (10(-5)M) strongly inhibited both types of the lipid peroxidation reactions and protected the resultant inactivation of the NADH-cytochrome c reductase activity. Activities of succinate oxidase in rat and canine brain mitochondria were virtually unaffected by CV-2619 and its metabolites (10(-5)-10(-6) M). On the other hand, CV-2619 markedly suppressed the state 3 respiration in glutamate oxidation in a dose dependent manner without any effect on the state 4 respiration and the ADP/O ratio in intact rat brain mitochondria. The inhibitory effect of CV-2619 was also observed in NADH-cytochrome c reductase, but not in NADH-2,6-dichlorophenolindophenol (DCIP) and NADH-ubiquinone reductases in canine brain mitochondria. These facts and results of inhibitor analysis suggest that the action site of CV-2619 is NADH-linked complex I in the mitochondrial respiratory chain and is different from that of inhibitors of oxidative phosphorylation such as rotenone, oligomycin and 2,4-dinitrophenol. Finally, the above findings suggest that CV-2619 acts as an electron carrier in respiratory chains and functions as an antioxidant against membrane damage caused by lipid peroxidation in brain mitochondria. It appears likely that the inhibition of oxygen consumption caused by CV-2619 is related to the effect on non-respiratory systems such as lipid peroxidation which also consumes oxygen.
研究了艾地苯醌(CV - 2619)及其代谢产物对大鼠和犬离体脑线粒体呼吸活性及脂质过氧化的影响。在存在呼吸底物的情况下,犬脑线粒体可轻易将CV - 2619还原。还原型CV - 2619(2H - CV - 2619)通过细胞色素b链迅速被氧化,表明该化合物仅作为线粒体呼吸系统的电子载体发挥作用。在二磷酸腺苷(ADP)和Fe3+存在的情况下,研究了犬脑线粒体中烟酰胺腺嘌呤二核苷酸(NADH)依赖性和烟酰胺腺嘌呤二核苷酸磷酸(NADPH)依赖性脂质过氧化。NADH - 细胞色素c还原酶活性对NADPH依赖性脂质过氧化敏感。CV - 2619(10^(-5)M)强烈抑制两种类型的脂质过氧化反应,并保护由此导致的NADH - 细胞色素c还原酶活性失活。CV - 2619及其代谢产物(10^(-5) - 10^(-6)M)对大鼠和犬脑线粒体中琥珀酸氧化酶的活性几乎没有影响。另一方面,CV - 2619以剂量依赖性方式显著抑制完整大鼠脑线粒体中谷氨酸氧化的状态3呼吸,而对状态4呼吸和ADP/O比值没有任何影响。在犬脑线粒体中,CV - 2619对NADH - 细胞色素c还原酶有抑制作用,但对NADH - 2,6 - 二氯酚靛酚(DCIP)还原酶和NADH - 泛醌还原酶没有抑制作用。这些事实以及抑制剂分析结果表明,CV - 2619的作用位点是线粒体呼吸链中与NADH相关的复合体I,与鱼藤酮、寡霉素和2,4 - 二硝基苯酚等氧化磷酸化抑制剂的作用位点不同。最后,上述发现表明,CV - 2619在呼吸链中作为电子载体发挥作用,并作为抗氧化剂防止脑线粒体中脂质过氧化引起的膜损伤。CV - 2619引起的氧消耗抑制似乎与对脂质过氧化等非呼吸系统的影响有关,脂质过氧化也消耗氧气。